Event Type
Disclosure
Voluntary
Variant
8-K
, including Exhibit 99.1 hereto, is being furnished herewith and shall not be deemed “filed” for the purposes of Section 18 of the Exchange Act, or otherwise su
. Other Events. As the Company reported on October 27, 2025, Grade 4 liver transaminases and increased total bilirubin were reported in a patient who was dosed
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Corporate Presentation 104 Cover Page Interactive Data File (embedded within the In